Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “targeted”

263 pharma patents match "targeted" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 263
Index total 30,257
Page 3 / 11

Quick answer

This filtered view shows 263 pharmaceutical patents matching "targeted" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

263 results for “targeted” · 30,257 patents in full index Clear search

  1. US 11459617

    Targeted measure of transcriptional activity related to hormone receptors

    The Board of Regents of the University of Texas System · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  2. US 11439666

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Sangamo Therapeutics, Inc. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  3. US 11427823

    Targeted compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  4. US 11407825

    NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  5. US 11384154

    Targeted chimeric proteins and uses thereof

    Orionis Biosciences, Inc · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

  6. US 11377447

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  7. US 11369683

    Systems and methods for targeted imaging and ablation of cardiac cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  8. US 11357860

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  9. US 11352631

    Targeted disruption of the T cell receptor

    Sangamo Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  10. US 11345904

    Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  11. US 11331346

    Targeted replacement of endogenous T cell receptors

    The Regents of the University of California · Granted May 17, 2022 · Expires May 12, 2042

    granted

  12. US 11311485

    Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer

    Northwestern University · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  13. US 11311574

    Methods and compositions for targeted cleavage and recombination

    Sangamo Therapeutics, Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  14. US 11298561

    Method of treating multi-drug resistance biofilm using targeted laser and antibiotics

    United States of America as represented by the Secretary of the Air Force · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  15. US 11292815

    Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

    Apellis Pharmaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  16. US 11285175

    Targeted disruption of the MHC cell receptor

    Sangamo Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  17. US 11273127

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  18. US 11253522

    Cancer treatment targeted to tumor adaptive responses to protein synthesis stress

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  19. US 11254725

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  20. US 11236141

    Targeted mutant interferon-beta and uses thereof

    Orionis Biosciences, Inc · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  21. US 11230607

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  22. US 11207339

    Targeted cancer therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  23. US 11197844

    Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  24. US 11185674

    Targeted delivery of biologic therapeutic agents

    Northwestern University · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.